CSPC Pharmaceuticals Group ADR (CSPCY) Stock Price & News

CSPC Pharmaceutical Group researches, develops, manufactures and sells pharmaceutical products. Its headquarters is in China's Hebei Province. CSPC produces both active pharmaceutical ingredient and formulations. API products include penicillin, cefalosporins, synthetic vitamins, caffeine and ranitidine. Formulations include antibiotics, butylphthalide and analgesics, in addition to nearly 1,000 other products. CSPC's 15,000 employees are divided among more than ten subsidiaries, including CSPC Zhongrun, Weisheng, Zhongnuo and NBP. CSPC Pharma's total assets are valued above RMB 8 billion. In 2007, CSPC Pharma achieved sales of RMB 8 billion and net income of RMB 485 million. Direct exports of US$300 million ranked CSPC first among China's pharmaceutical enterprises. One subsidiary, China Pharmaceutical Group Co., Ltd is based in Hong Kong. It is listed on the Hang Seng China-Affiliated Corporations Index. In 2003 and 2004, China Pharma was listed as one of 100 excellent listed companies with turnover less than $1 billion. CSPC Pharma is recognized as one of China's "500 Most Valuable Chinese Brands" and "Top 500 Chinese Enterprises." Wikipedia

About CSPC Pharmaceuticals Group ADR

CEOZhang Cuilong

Employees18,6 миң

Founded1992

Headquarters-

SectorPharmaceutical industry

Websitecspc.com.hk

All values in CNY	2025-ж. сен.	2025-ж. дек.	2026-ж. мар.	2026-ж. июн.
Revenue	6,62 млд	6,11 млд	6,47 млд	12,13 млд
Cost of goods sold	2,28 млд	2,11 млд	2,20 млд	2,24 млд
Cost of revenue	2,28 млд	2,11 млд	2,20 млд	2,24 млд
Research and development expenses	1,50 млд	1,62 млд	1,40 млд	1,63 млд
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	1,97 млд	1,87 млд	1,89 млд	1,89 млд
Operating expense	3,47 млд	3,49 млд	3,29 млд	3,51 млд
Total operating expenses	5,75 млд	5,60 млд	5,49 млд	5,75 млд
Operating income	869,63 млн	514,71 млн	973,82 млн	6,38 млд
Other non operating income	645,14 млн	-470,42 млн	181,80 млн	11,92 млн
EBT including unusual items	1,18 млд	505,59 млн	1,13 млд	6,40 млд
EBT excluding unusual items	1,37 млд	186,56 млн	1,13 млд	6,35 млд
Income tax expense	222,47 млн	165,64 млн	243,25 млн	825,70 млн
Effective tax rate	18,78%	32,76%	21,46%	12,91%
Other operating expenses	-	-	-	-
Net income	963,54 млн	370,72 млн	859,79 млн	5,23 млд
Net profit margin	14,56%	6,06%	13,30%	43,16%
Earnings per share	-	-	-	-
Interest and investment income	-	195,87 млн	-	91,68 млн
Interest expense	-104,94 млн	-6,76 млн	-11,01 млн	-2,30 млн
Net interest expenses	-104,94 млн	189,12 млн	-11,01 млн	89,37 млн
Depreciation and amortization charges	-	-	-	-
EBITDA	1,14 млд	802,06 млн	1,26 млд	6,67 млд
Gain or loss from assets sale	-	-	-	-

Finance

Ask anything